> For the complete documentation index, see [llms.txt](https://docs.countercyclical.io/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://docs.countercyclical.io/companies-funds-and-entities/end-to-end-source-attribution.md).

# End-To-End Source Attribution

Trace a figure or excerpt to the source used in your research.

Source attribution shows where a figure or passage came from. Countercyclical can surface references to filings or providers in supported financial views and to supporting passages in workspace research. The information displayed depends on the available source.

### Reading Financial Sources

Select the cell or range in a financial table and open **Source** or **Sources** where offered. The panel can show the line item, reported value, formula, currency, symbol, period, and filing or provider metadata.

For a calculation, the panel may list more than one source. Review the formula and each source separately when you need to verify the inputs. Where available, open the filing or provider link to inspect the original material.

### Reading Inline References

Open an inline source marker in a memo or another supported workspace resource to view its citation. It can show a title, excerpt, publisher, reference, or section. Follow the source link for the original context.

Keep the reference attached when copying a claim into another document or summarize its publisher and location so the next reader can check the same evidence.

### Coverage and Access

A source can be listed without a direct link when a location is unavailable. For regulatory disclosures, search the company’s Filings tab using the filing type and date shown. For connected material, the original provider’s access rules apply.

{% hint style="info" %}
Check the source’s reporting period and units before comparing it with another figure. A filing date and an accounting period refer to different dates.
{% endhint %}

### Related Pages

{% content-ref url="/pages/YNdp08H3Zf8iBFYobRx8" %}
[Filings](https://docs.countercyclical.io/companies-funds-and-entities/filings.md)
{% endcontent-ref %}

{% content-ref url="/pages/ugB5WtkGWTCCrr0DWfYA" %}
[Transcripts](https://docs.countercyclical.io/companies-funds-and-entities/transcripts.md)
{% endcontent-ref %}

{% content-ref url="/pages/Xe5gK7qOTjQ5jHaVfEZk" %}
[Memos](https://docs.countercyclical.io/workspaces/memos.md)
{% endcontent-ref %}

{% content-ref url="/pages/OBK7u6S57mR3HyiB90vY" %}
[Enriched Tooltip Formula Helpers](https://docs.countercyclical.io/companies-funds-and-entities/enriched-tooltip-formula-helpers.md)
{% endcontent-ref %}
